# Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects

> **NCT00667797** · PHASE4 · COMPLETED · sponsor: **Sumitomo Pharma America, Inc.** · enrollment: 486 (actual)

## Conditions studied

- Asthma
- COPD

## Interventions

- **DRUG:** levalbuterol HCl
- **DRUG:** albuterol Sulfate

## Key facts

- **NCT ID:** NCT00667797
- **Lead sponsor:** Sumitomo Pharma America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2005-05
- **Final completion:** 2005-05
- **Target enrollment:** 486 (ACTUAL)
- **Last updated:** 2012-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00667797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00667797, "Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00667797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*